Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28601 - 28625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	PLAC9	219348	downregulated	Cytarabine results in decreased expression of PLAC9 mRNA	10q22.3	A21886
Cytarabine	Approved Investigational	PLAT	5327	downregulated	Cytarabine results in decreased expression of PLAT mRNA	8p11.21	A21886
Cytarabine	Approved Investigational	PLCH1	23007	upregulated	Cytarabine results in increased expression of PLCH1 mRNA	3q25.31	A21886
Cytarabine	Approved Investigational	PLD3	23646	downregulated	Cytarabine results in decreased expression of PLD3 mRNA	19q13.2	A21886
Cytarabine	Approved Investigational	PLEKHG3	26030	downregulated	Cytarabine results in decreased expression of PLEKHG3 mRNA	14q23.3	A21886
Cytarabine	Approved Investigational	PLIN3	10226	downregulated	Cytarabine results in decreased expression of PLIN3 mRNA	19p13.3	A21886
Cytarabine	Approved Investigational	PLLP	51090	downregulated	Cytarabine results in decreased expression of PLLP mRNA	16q13	A21886
Cytarabine	Approved Investigational	PLOD1	5351	downregulated	Cytarabine results in decreased expression of PLOD1 mRNA	1p36.22	A21886
Cytarabine	Approved Investigational	PLP1	5354	upregulated	Cytarabine results in increased expression of PLP1 mRNA	Xq22.2	A21886
Cytarabine	Approved Investigational	PLTP	5360	downregulated	Cytarabine results in decreased expression of PLTP mRNA	20q13.12	A21886
Cytarabine	Approved Investigational	PMEL	6490	upregulated	Cytarabine results in increased expression of PMEL mRNA	12q13.2	A21886
Cytarabine	Approved Investigational	PMP22	5376	downregulated	Cytarabine results in decreased expression of PMP22 mRNA	17p12	A21886
Cytarabine	Approved Investigational	PODXL	5420	downregulated	Cytarabine results in decreased expression of PODXL mRNA	7q32.3	A21886
Cytarabine	Approved Investigational	PODXL2	50512	upregulated	Cytarabine results in increased expression of PODXL2 mRNA	3q21.3	A21886
Cytarabine	Approved Investigational	POSTN	10631	downregulated	Cytarabine results in decreased expression of POSTN mRNA	13q13.3	A21886
Cytarabine	Approved Investigational	POU5F1P4	645682	downregulated	Cytarabine results in decreased expression of POU5F1P4 mRNA	1q22	A21886
Cytarabine	Approved Investigational	PPIC	5480	downregulated	Cytarabine results in decreased expression of PPIC mRNA	5q23.2	A21886
Cytarabine	Approved Investigational	PPM1M	132160	downregulated	Cytarabine results in decreased expression of PPM1M mRNA	3p21.2	A21886
Cytarabine	Approved Investigational	PPT2	9374	downregulated	Cytarabine results in decreased expression of PPT2 mRNA	6p21.32	A21886
Cytarabine	Approved Investigational	PRC1	9055	downregulated	Cytarabine results in decreased expression of PRC1 mRNA	15q26.1	A20666
Cytarabine	Approved Investigational	PRDM8	56978	upregulated	Cytarabine results in increased expression of PRDM8 mRNA	4q21.21	A21886
Cytarabine	Approved Investigational	PRICKLE1	144165	downregulated	Cytarabine results in decreased expression of PRICKLE1 mRNA	12q12	A21886
Cytarabine	Approved Investigational	PRNP	5621	downregulated	Cytarabine results in decreased expression of PRNP mRNA	20p13	A21886
Cytarabine	Approved Investigational	PRPH	5630	downregulated	Cytarabine results in decreased expression of PRPH mRNA	12q13.12	A21886
Cytarabine	Approved Investigational	PRRC2C	23215	downregulated	Cytarabine results in decreased expression of PRRC2C mRNA	1q24.3	A20985

Displaying entries 28601 - 28625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability